The Specific Roles of JAK/STAT Signaling Pathway in Sepsis
- PMID: 25676437
- DOI: 10.1007/s10753-015-0135-z
The Specific Roles of JAK/STAT Signaling Pathway in Sepsis
Abstract
The Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway is a principal signaling pathway for the signal transduction of many pivotal cytokines involved in sepsis. Binding of cytokines to corresponding receptors can activate associated JAK kinases, which selectively phosphorylate STATs. Activated STATs then translocate to the nucleus and play a critical role in the transcription of target genes. During the past several years, significant progress has been made in the understanding of the roles of JAK/STAT pathway in sepsis. The aims of this review are to describe the present knowledge about JAK/STAT signaling pathway, describe the specific roles of JAK/STAT pathway in sepsis, and put forward the prospect for future studies of JAK/STAT signaling pathway in sepsis. A PubMed database search was performed for studies of JAKs and STATs in sepsis. It has been shown that a variety of cytokines can exert their biological effects via the JAK/STAT signaling pathway. JAK/STAT pathway has been shown related to the release of various cytokines and inflammatory mediators and involved in the regulation of immune response in sepsis. Moreover, JAK/STAT pathway has been shown involved in organ damage and other dysfunctions in sepsis models.
Similar articles
-
Pleiotropy and redundancy of STAT proteins in early pregnancy.Reprod Domest Anim. 2007 Aug;42(4):343-53. doi: 10.1111/j.1439-0531.2006.00787.x. Reprod Domest Anim. 2007. PMID: 17635769 Review.
-
JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases.Int J Mol Sci. 2023 Jun 17;24(12):10290. doi: 10.3390/ijms241210290. Int J Mol Sci. 2023. PMID: 37373437 Free PMC article. Review.
-
Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.Crit Rev Immunol. 2015;35(6):505-27. doi: 10.1615/CritRevImmunol.2016015517. Crit Rev Immunol. 2015. PMID: 27279046 Free PMC article. Review.
-
STAT proteins in innate immunity during sepsis: lessons from gene knockout mice.Acta Med Okayama. 2007 Oct;61(5):239-45. doi: 10.18926/AMO/32897. Acta Med Okayama. 2007. PMID: 17971840 Review.
-
The JAK-STAT pathway: a therapeutic target in hematological malignancies.Curr Cancer Drug Targets. 2006 Dec;6(8):671-9. doi: 10.2174/156800906779010227. Curr Cancer Drug Targets. 2006. PMID: 17168672 Review.
Cited by
-
Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses.Front Immunol. 2024 Feb 20;15:1341632. doi: 10.3389/fimmu.2024.1341632. eCollection 2024. Front Immunol. 2024. PMID: 38444845 Free PMC article. Review.
-
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.Mol Divers. 2024 Jan 18. doi: 10.1007/s11030-023-10794-5. Online ahead of print. Mol Divers. 2024. PMID: 38236444 Review.
-
Total alkaloids of bulbus of Fritillaria cirrhosa alleviate bleomycin-induced inflammation and pulmonary fibrosis in rats by inhibiting TGF-β and NF-κB signaling pathway.Food Nutr Res. 2023 Dec 29;67. doi: 10.29219/fnr.v67.10292. eCollection 2023. Food Nutr Res. 2023. PMID: 38187805 Free PMC article.
-
Research progress on the mechanism of astragaloside IV in the treatment of asthma.Heliyon. 2023 Nov 10;9(11):e22149. doi: 10.1016/j.heliyon.2023.e22149. eCollection 2023 Nov. Heliyon. 2023. PMID: 38045181 Free PMC article. Review.
-
The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R/JAK2/STAT1 pathway-mediated high-mobility group box-1 release.Burns Trauma. 2023 Oct 15;11:tkad023. doi: 10.1093/burnst/tkad023. eCollection 2023. Burns Trauma. 2023. PMID: 38026444 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
